[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"avm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:avm":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,79],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100578009","this-three-year-observational-study-involves-patients-of-all-ages-undergoing-endovascular-treatment-for-various-cerebral-or-spinal-vascular-conditions-it-aims-to-assess-pre--and-post-operative-clinical-conditions-report-complications-and-identify-preoperative-indicators-of-treatment-outcomes-pat-100578009",false,"NCT06805721","This Three-year Observational Study Involves Patients of All Ages Undergoing Endovascular Treatment for Various Cerebral or Spinal Vascular Conditions. It Aims to Assess Pre- and Post-operative Clinical Conditions, Report Complications, and Identify Preoperative Indicators of Treatment Outcomes. Pat","OUTCOME IN NEURORADIOLOGIA INTERVENTISTICA INDICAZIONI COMPLICANZE (ONIRIC)","ONIRIC","Inclusion Criteria:\n\n* Patients of both sexes and any age, who are referred to the Department of Neurosurgery and Clinical Neurosciences and are candidates for interventional endovascular procedures for any cerebral or spinal pathology, will be included in the study.\n\nExclusion Criteria:\n\n* \u002F","ALL",{"count":19,"type":20},1000,"ESTIMATED","OBSERVATIONAL","This three-year observational study involves patients of all ages undergoing endovascular treatment for various cerebral or spinal vascular conditions. It aims to assess pre- and post-operative clinical conditions, report complications, and identify preoperative indicators of treatment outcomes. Patients will also receive psychological support and Neuropsychological assessment. Clinical, medical, and demographic data will be recorded in a database during hospitalization and follow-up visits.",[24,25,26,27],"Aneurysm Cerebral","AVM","DAFV","ESDC",[29,30,31,25,32],"Endovascular treatment","Neurospychological assessment","Aneurysm","Psychological Outcome","RECRUITING","2026-03-25",{"date":36,"type":37},"2026-03-27","ACTUAL",{"date":39,"type":37},"2023-02-06",{"date":41,"type":20},"2029-01",{"name":43,"class":44},"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":57,"conditions":58,"keywords":65,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":78},"100433671","safety-performance-and-usability-of-balt-medical-devices-the-evidence-post-marketing-clinical-follow-up-platform-100433671","NCT04927156","Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform","Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform. An International, Multicenter, Prospective, and Retrospective Data Collection","EVIDENCE","Inclusion Criteria:\n\n* Provision of a signed, written and dated informed consent or non-opposition (where applicable)\n\nExclusion Criteria\n\n* Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)\n* Contra-indications of each device as described in the instructions for use.","2 Years",{"count":56,"type":20},10000,"BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices.\n\nThis platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.",[59,60,61,62,63,25,64],"Intracranial Aneurysm","Brain Arterial Disease","Acute Ischemic Stroke","Peripheral Vascular Diseases","AVM - Cerebral Arteriovenous Malformation","Fistulas Arteriovenous",[66,67],"catheter","guidewire","2025-09-16",{"date":70,"type":37},"2025-09-18",{"date":72,"type":37},"2021-07-12",{"date":74,"type":20},"2041-10",{"name":76,"class":77},"Balt Extrusion","INDUSTRY",12,{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":17,"minAge":87,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":89,"phases":90,"briefSummary":92,"conditions":93,"keywords":98,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":116},"100216702","treatment-of-brain-avms-tobas-study-100216702","NCT02098252","Treatment of Brain AVMs (TOBAS) Study","Treatment of Brain AVMs (TOBAS) Study: A Randomized Controlled Trial and Registry","TOBAS","Inclusion Criteria:\n\n* Any patient with a brain AVM\n\nExclusion Criteria:\n\n* Hemorrhagic presentation with mass effect requiring surgical management. In these cases, if a residual AVM is found after the initial surgery, the patient could then be a candidate for TOBAS.","5 Years",{"count":19,"type":20},"INTERVENTIONAL",[91],"NA","The objectives of this study and registry are to offer the best management possible for patients with brain arteriovenous malformations (AVMs) (ruptured or unruptured) in terms of long-term outcomes, despite the presence of uncertainty. Management may include interventional therapy (with endovascular procedures, neurosurgery, or radiotherapy, alone or in combination) or conservative management.\n\nThe trial has been designed to test a) whether medical management or interventional therapy will reduce the risk of death or debilitating stroke (due to hemorrhage or infarction) by an absolute magnitude of about 15% (over 10 years) for unruptured AVMs (from 30% to 15%); and, b) to test if endovascular treatment can improve the safety and efficacy of surgery or radiation therapy by at least 10% (80% to 90%).\n\nAs for the nested trial on the role of embolization in the treatment of Brain AVMs by other means: the pre-surgical or pre-radiosurgery embolization of cerebral AVMs can decrease the number of treatment failures from 20% to 10%. In addition,embolization of cerebral AVMs can be accomplished with an acceptable risk, defined as permanent disabling neurological complications of 8%.",[94,95,96,25,97],"Unruptured Brain Arteriovenous Malformation","Ruptured Brain Arteriovenous Malformation","Arteriovenous Malformations","BAVM",[99,96,25,97,100,101,102,31,103,104,105,106],"brain arteriovenous malformation","Stroke","Intracranial Hemorrhage","Congenital Abnormalities","Vascular Malformations","Cardiovascular Abnormalities","Cardiovascular Diseases","Vascular Diseases","2024-08-13",{"date":109,"type":37},"2024-08-15",{"date":111,"type":4},"2014-05",{"date":113,"type":20},"2036-01",{"name":115,"class":44},"Centre hospitalier de l'Université de Montréal (CHUM)",30]